New drugs drive rising sales at Bayer

German group shifts toward life sciences

Sanofi board ousts chief executive

Viehbacher’s departure follows tensions with directors

‘Style’ clash cited in Sanofi ouster

Board dumps chief executive despite brightening outlook

Norway’s oil fund hit by European stocks

First negative quarterly return on equities in more than two years

Sanofi logo
©Getty Images

Sanofi: finding the energy

Competition in the insulin market is hurting. So are rumours about the management

Pfizer: tax inversions still have ‘value’

US drugs group beats earnings expectations

Gilead’s hepatitis C drug breaks records

Thousand-dollar price tag puts pressure on US healthcare system

Fears over flat sales hit Sanofi shares

Group warns over increased competition in US for diabetes drugs

Novartis profits given boost by disposals

Idenix Pharmaceuticals stake sale adds to emerging markets rise

US issues guidelines over Ebola

White House seeks to end dispute over quarantine of medical workers

R&D spending unlinked to performance, says study

Findings will deepen debate on European research expenditure

Valeant set to sweeten bid for Allergan

Canadian group offers to boost bid to $60bn to force talks

Cuomo backs down on NY Ebola orders

Governor follows White House warnings about consequences of quarantine

Companies train to deal with dementia

Businesses adapting to demands of ageing population

Japan embraces future of robot carers

Devices set to fill the gap left by a shrinking number of workers

Apps at the heart of new age of medicine

Technology can help the ill and elderly stay independent longer

Silicon Valley joins quest to ‘cure’ ageing

Google has invested hundreds of millions of dollars through secretive start-up Calico

Succession planning faces tighter climate

FRC to consider making handover arrangements a permanent exercise

US governors order Ebola quarantine

Medical worker isolated in New Jersey tests negative for virus

UK drugmakers show standalone strength

Record results for Shire; AstraZeneca wins backing for new drug


More FT Twitter accounts